5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 15.34▲ | 15.35▼ | 15.21▲ | 14.40▲ | 13.57▲ |
MA10 | 15.36▼ | 15.18▲ | 15.06▲ | 13.94▲ | 13.33▲ |
MA20 | 15.35▲ | 14.96▲ | 14.59▲ | 13.44▲ | 12.01▲ |
MA50 | 15.16▲ | 14.25▲ | 13.95▲ | 13.22▲ | 12.32▲ |
MA100 | 15.01▲ | 13.90▲ | 13.69▲ | 12.13▲ | 12.02▲ |
MA200 | 14.56▲ | 13.55▲ | 13.89▲ | 12.34▲ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.015▼ | 0.006▲ | 0.062▲ | 0.167▲ | 0.378▲ |
RSI | 55.594▲ | 75.696▲ | 74.252▲ | 62.093▲ | 59.305▲ |
STOCH | 39.427 | 82.025▲ | 91.590▲ | 72.259 | 54.107 |
WILL %R | -51.064 | -16.901▲ | -8.511▲ | -4.444▲ | -29.885 |
CCI | -38.474 | 96.465 | 105.868▲ | 227.557▲ | 67.498 |
Thursday, May 01, 2025 06:45 AM
Though insider buying has slowed during the first-quarter reporting season, some insiders continued to build stakes or bucked selling trends.
|
Monday, April 28, 2025 06:00 AM
Mineralys Therapeutics, Inc. (Nasdaq: MLYS) announced the publication of groundbreaking Phase 2 trial results for its medication lorundrostat in the New England Journal of Medicine (NEJM). The ...
|
Wednesday, April 23, 2025 02:30 PM
Mineralys Therapeutics, Inc. has announced the publication of detailed results from its pivotal Phase 2 Advance-HTN trial in the New England Journal of Medicine. The study assessed lorundrostat ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
02/05/25 | 15.17 | 15.47 | 15.15 | 15.35 | 116,222 |
01/05/25 | 14.22 | 15.0856 | 13.96 | 14.96 | 1,077,434 |
30/04/25 | 14.00 | 14.48 | 13.725 | 14.21 | 996,107 |
29/04/25 | 13.40 | 13.95 | 13.15 | 13.94 | 399,487 |
28/04/25 | 13.39 | 14.11 | 13.195 | 13.56 | 582,659 |
25/04/25 | 13.79 | 13.97 | 12.90 | 13.34 | 827,575 |
24/04/25 | 13.68 | 14.1599 | 13.3842 | 14.09 | 394,572 |
23/04/25 | 13.40 | 14.14 | 13.40 | 13.53 | 536,530 |
22/04/25 | 13.49 | 13.625 | 12.94 | 13.21 | 502,760 |
21/04/25 | 13.27 | 13.6713 | 12.77 | 13.24 | 638,842 |
|
|
||||
|
|
||||
|
|